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Abstract
Background: Relationship between carotid and coronary artery disease (CAD) in patients undergoing invasive and
non-invasive test is unclear. The aim of the study is to evaluate whether carotid disease is associated with CAD in
patients submitted to exercise echocardiography (EE) and if it improves the EE ability to predict CAD.
Methods: We retrospectively studied 156 subjects without previous vascular disease who underwent EE, carotid
ultrasonography and coronary angiography between 2002 and 2013. Positive EE was defined as exercise induced
wall motion abnormalities, carotid disease according to Manheim and American Society of Echocardiography
Consensus and significant CAD as stenosis ≥50%.
Results: Eighty-nine (57.1%) subjects had significant CAD. Factors associated with CAD in multivariate analysis were
fasting plasma glucose (odds ratio [OR] 1.02, p = 0.031), pre-test probability of CAD > 65% (OR 3.71, p < 0.001),
positive EE (OR 10.51, p < 0.001) and carotid plaque (CP) presence (OR 2.95, p = 0.013). There was neither statistical
significant difference in area under the curve after addition of CP to EE results (0.77 versus 0.81, p = 0.525) nor sensitivity,
specificity, predictive values or efficiency. CP presence reclassified as very high-risk according to Systematic COronary Risk
Evaluation 13 patients (34.2%) with negative EE and 22 (33.3%) without CAD.
Conclusion: CP is associated with CAD in patients undergoing EE, however its addition to EE does not improve CAD
prediction, probably due to insufficient statistical power. CP reclassified one third of patients to very high-risk category
despite negative EE or CAD absence, these subjects benefit from aggressive primary prevention interventions.
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Background
Ischaemic heart disease is a major problem due to its
prevalence, health cost and mortality [1–3]. Stress echo-
cardiography is a well-validated tool for diagnosis and
risk stratification in patients with new onset chest pain,
but it has some limitations that can impair its diagnostic
capacity such as the dependence of pre-test probabilities
(PTP) of coronary artery disease (CAD), the need to
achieve submaximal heart rate, the presence of subopti-
mal echocardiographic windows, the inability to detect
non limiting flow coronary stenosis or pathologies that
can produce wall motion abnormalities during exercise
[2–4].
Carotid disease, defined as increased carotid
intima-media thickness (CIMT) or the presence of ath-
erosclerotic plaques (CP), has been associated with myo-
cardial infarction, stroke and death [5–7]. Post-mortem
studies have also demonstrated a correlation between ca-
rotid and CAD [8]. These findings encouraged
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investigators to evaluate the possibility of using carotid
disease in the diagnosis of CAD of patients undergoing
invasive and non-invasive tests, however the studies
published so far have shown inconsistent results [9–19].
In that sense a meta-analysis of 34 studies focused on
the relation of CIMT with coronary atherosclerosis, 30
showed a positive but modest relationship with correl-
ation positive coefficients between 0.12 and 0.51 with
only one study being above 0.5 and some studies showed
no relationship at all [19].
Our group has broad experience in the ultrasono-
graphic assessment of carotid arteries, having demon-
strated its usefulness as a marker of subclinical
atherosclerosis in subjects with autoimmune diseases
[20]. The studies mentioned before [5–8], along with
our findings, led to the systematic use of carotid ultra-
sound in subjects with suspected CAD undergoing exer-
cise echocardiography (EE) at our cardiovascular imaging
laboratory since 2002. This approach has been endorsed
by the European Society of Cardiology (ESC) stable CAD
guidelines as a IIa level C recommendation [2].
A clinical study was designed to evaluate if carotid dis-
ease is associated with significant CAD in patients with
suspected ischaemic heart disease undergoing treadmill
exercise stress echocardiography at our institution and if
it improves the EE ability to predict significant CAD.
Methods
Study population
Between Jan. 1st 2002 and Dec. 31st 2013 4024 consecu-
tive Caucasian subjects older than 18 years with sus-
pected CAD underwent EE and carotid ultrasonography
at our institution. Of them, 390 patients (9.7%) were also
submitted to a coronary angiography. 234 patients (60%)
were excluded: 29 (7.4%) due to prior stroke, transient
ischaemic attack or peripheral artery disease and 205
due to prior CAD (52.6%) defined as previous myocar-
dial infarction [21], coronary revascularization or angio-
graphic documentation of any coronary stenosis ≥50%.
All patients signed informed consent before testing. The
study was approved by the Regional Ethics Committee.
Demographic, clinical, baseline echocardiography, ca-
rotid ultrasonography and stress testing data were col-
lected. PTP of CAD and Systematic COronary Risk
Evaluation (SCORE) were assessed according to current
ESC guidelines [1, 2].
Treadmill exercise stress echocardiography
Treadmill exercise was the stress modality chosen using
a Philips Sonos 5500 ultrasound machine between 2002
and 2005 and a Philips iE33 after 2005 (Philips Medical
Systems).
Heart rate, blood pressure and 12-lead electrocardio-
gram were obtained at baseline and at each exercise
stage. EE was finished in case of physical exhaustion, dis-
abling chest pain, significant arrhythmia and severe
hypertensive or hypotensive response. Apical long-axis,
apical 4- and 2-chamber and parasternal long- and
short-axis views were obtained at rest, peak and immedi-
ately after exercise. Echocardiographic analysis was per-
formed using a 17-segment model of the left ventricle to
evaluate regional wall motion. Each segment was graded
on a 4-point scale depending on its motion. Wall motion
score index was calculated as the sum of the scores di-
vided by the number of segments at rest and at peak
exercise.
Ischaemic electrocardiographic abnormalities were
defined as development of ST-segment deviation 80 msec
after J point ≥1 mm. Echocardiographic ischaemia was
defined as exercise induced new or worsening wall
motion abnormalities, except worsening from akinesia to
dyskinesia and isolated hypokinesia of the inferobasal
segment. Extensive ischemia was defined as ischaemia
involving ≥3 myocardial segments and multivessel
ischemia as ischemia involving ≥2 different coronary ter-
ritories [4].
Carotid ultrasonography
Carotid scans were performed immediately after stress
testing in the same EE ultrasound equipment using a
high-resolution, B-mode ultrasound system with a linear
array (3–11 MHz) transducer. Measurement of the
CIMT and CP definition were done following the ARIC
protocol study [5] and expert consensus [22–25].
Semi-automated edge detection software was used
(QLAB; Philips 110 Medical Systems, Andover, MA,
USA).
Age- and sex-specific CIMT percentile values were ob-
tained from previously published data in our country
[26].
Both EE and carotid ultrasonography stored images
were analysed by two imaging expert cardiologists
blinded to angiography results. In case of disagreement a
third expert was consulted.
Coronary angiography
The physician in charge of the patient carried out a
coronary angiography considering the results of the EE
and other conditions such as persistence of symptoms
despite optimal medical treatment, patients’ preferences
and/or other clinical criteria. Coronary angiography was
performed using standard technique. Significant angio-
graphic disease was defined as stenosis ≥50% by visual
assessment in any major epicardial arteries or in their
branches.
Coronary angiography analysis was similar to
ultrasonography.
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Statistical analysis
Categorical variables were reported as percentages and
comparison between groups were based on chi-square
or Fisher’s exact tests. Continuous variables were re-
ported as mean (standard deviation) or median [inter-
quartile range] when their distribution departed from
normal and differences were assessed via the unpaired t
test or the Mann-Whitney U test where appropriate.
Binary and continuous quantitative variables were com-
pared using logistic binary regression. To create predict-
ive models for the presence of significant CAD,
backward stepwise binary logistic regression was used
with an entry set at 0.2 significance level and a retention
set of 0.1. A p value of < 0.05 was considered statistically
significant. ! DT V2009.06.26® macro for SPSS Statistics
(Autonomous University of Barcelona) and IBM SPSS
Statistics for Windows, Version 20.0. (Armonk, NY) was
used to calculate sensitivity, specificity, positive (PPV)
and negative predictive values (NPV), positive (PLR) and
negative likelihood ratios (NLR) and efficiency of EE
alone and combined with carotid ultrasonography. Area
under the curve (AUC) was calculated by means of a re-
ceiver operating characteristic curve analysis; compari-
son between AUC was done by the DeLong method.
Results
One hundred fifthy six patients were enrolled in the
study. Mean age was 66.1 ± 10.4 years and 102 (65.4%)
were men. There were no major complications during or
after the tests.
Baseline characteristics are summarized in Table 1.
Prediction of CAD
Mean time between non-invasive tests and coronary
angiography was 4.2 (3.2) months. Of the 156 patients
89 (57.1%) had significant CAD. This subgroup was
older (p = 0.045), with male predominance (p = 0.011), had
more frequently diabetes mellitus (DM), smoking habit
(p = 0.023) and higher levels of fasting plasma glucose
(FPG) (p = 0.003). Higher SCORE, PTP of CAD as well as
positive EE and CP presence (all of them p < 0.001) were
also significantly more frequent in patients with CAD.
In multivariate analysis FPG (p = 0.031), PTP > 65%
(p < 0.001), positive EE (p < 0.001) and CP (p = 0.013)
were predictors of significant CAD.
Comparisons of subgroups with and without signifi-
cant CAD and multivariate analysis are represented in
Tables 2 and 3 respectively.
Regarding the subgroup of 21 (13.6%) subjects with
resting wall motion abnormalities 4 (19%) had global left
ventricular hypokinesia. Of the 21 patients 17 (81.0%)
developed worsening wall motion abnormalities during
EE and all of them showed significant CAD in the angi-
ography, 2 (9.5%) were defined as negative EE and did
not have significant CAD and 2 (9.5%) could not achieve
submaximal predicted heart rate, both without significant
CAD in the angiography.
AUC, sensitivity, specificity, predictive values, PLR and
NLR and efficiency
AUC of EE alone was 0.77 (95% confidence interval [CI]
0.68–0.86), whereas AUC combining CP findings was
0.81 (95%CI 0.70–0.92) (p = 0.525). Results are summa-
rized in Fig. 1 and Table 4.
Sensitivity, specificity, predictive values, PLR and NLR
and efficiency of EE alone and EE combined with CP are
also summarized in Table 4. Table 5 shows predictive
values according to established intermediate PTP.
SCORE reclassification according to carotid ultrasound
According to European guidelines on cardiovascular
disease prevention [1] 10 subjects (6.4%) had low-risk at
the time of EE, 52 (33.3%) had moderate-risk, 47 (30.1%)
had high-risk, 45 (28.8%) had very high-risk and 2
patients (1.3%) could not be classified. When carotid
ultrasonography findings were applied 59 patients
(37.8%) were reclassified as very high-risk according to
CP presence. Focusing in the 62 patients with low or
moderate SCORE risk, 28 (45.2%) had CP.
Of the 38 patients with negative EE 5 subjects (13.2%),
16 (42.1%), 10 (26.3%) and 7 (18.4%) had low, moderate,
high and very high-risk respectively. Considering CP
presence 13 patients (34.2%) were reclassified as very
high-risk. Regarding the 21 patients with low or moder-
ate SCORE risk and negative EE, 7 (33.3%) had CP being
thereby considered as very high-risk.
Finally, of the 67 patients without CAD, 9 subjects
(13.4%) had low-risk, 28 (41.8%) had moderate-risk, 19
(28.4%) had high-risk, 10 (14.9%) had very high-risk and
1 (1.5%) could not be classified. Considering CP results,
22 patients (33.3%) were classified as very high-risk des-
pite normal angiography. Of the 37 patients without sig-
nificant CAD initially classified as low or moderate
SCORE risk 12 (32.4%) presented CP.
Discussion
This study correlates carotid disease with CAD in a real
life cohort of patients without prior vascular disease
undergoing EE. However, its addition to stress test does
not improve CAD prediction by angiography. It is neces-
sary to highlight the fact that nearly one third of patients
with negative EE and without CAD are reclassified to
high-risk group according to carotid ultrasonography
findings.
Akosah et al. [13] found an association between
carotid (CP or maximal CIMT ≥1 mm) and CAD in 236
patients referred for elective coronary angiography with
a high NPV in case of both negative tests. However, only
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162 (68.6%) subjects had stress test performed (the type
was not described in their study) with a low PPV (36%)
and also 95%CI were not reported. Kanwar et al. [14] re-
ported a study on 50 symptomatic patients without prior
CAD who underwent coronary angiography after stress
testing. CP, especially those with heterogeneous compos-
ition, irregular surface or calcification, was a predictor of
significant CAD showing a NPV of 100% in patients
with negative/equivocal stress test and CP absence. In
contrast to our study, 28% were non-Caucasians and
they used different modalities of stress imaging test with
a high incidence (64%) of equivocal results. Coskun et al.
[15] identified hypertension and CIMT ≥1 mm as pre-
dictors of significant CAD in patients without previous
CAD or stroke, scheduled for coronary angiography after
a positive stress test. Similarly to Akosah et al. [13], the
PPV of the stress test was lower compared to our results
(61%). Finally, Ahmadvazir et al. [16] identified PTP,
positive stress test and presence of CP as predictors of
significant CAD in 591 patients with suspected CAD
undergoing stress echocardiography. As in previous
studies, the NPV combining stress test and carotid ultra-
sonography was high (80%) and, in agreement with our
findings, nearly one third of the patients were reclassi-
fied for risk score according to CP results. However, only
35% of their patients were Caucasian, exercise as stress
method was only used in 62% and only 83 (14%) under-
went coronary angiography and, similar to the other
Table 1 Baseline characteristics of patients
Non-prior vascular disease
(n = 156)
Age (years) 66.1 (10.4)
Male sex (%) 102 (65.4%)
Body mass index (Kg/m2) 28.7 (4.0)
Hypertension 93 (59.6%)
Hypercholesterolemia 91 (58.3%)
DM 41 (26.3%)
Smoking habit 68 (43.6%)
Family history of premature CAD 22 (14.1%)
SCORE
Low 10 (6.4%)
Moderate 52 (33.3%)
High 47 (30.1%)
Very high 45 (28.8%)
Chest pain 149 (95.5%)
Typical 82 (55.0%)
Atypical 65 (43.6%)
Non-anginal 2 (1.3%)
FPG levels (mg/dL) 114.3 (33.5)
GFR (ml//min/1.73 m2) 78.3 (24.0)
Total Cholesterol levels (mg/dL) 189.2 (44.7)
Low-density lipoprotein levels (mg/dL) 114.4 (38.5)
High-density lipoprotein levels (mg/dL) 44.1 (11.7)
Triglyceride levels (mg/dL) 159.1 (94.1)
Drugs prior EE
Beta-blockers 36 (23.1%)
Calcium channel blockers 40 (25.6%)
Nitrates 23 (14.7%)
Statins 68 (43.6%)
Antiplatelet drugs 51 (32.7%)
EE data
Systolic BP (mmHg)
Rest 141.5 (20.3)
Peak 184.9 (29.3)
Heart rate (beats/min)
Rest 69.9 (13.1)
Peak 131.6 (18.6)
Rate-pressure (× 103 mmHg beats/min)
Rest 9.9 (2.5)
Peak 24.4 (5.6)
Exercise time (min) 6.9 (2.7)
Positive EE 93 (59.6%)
Negative EE 38 (24.4%)
Failure to achieve submaximal predicted
heart rate
25 (16.0%)
Table 1 Baseline characteristics of patients (Continued)
Non-prior vascular disease
(n = 156)
Metabolic equivalents 7.5 (2.6)
Left ventricular ejection fraction (%)
Rest 62.5 (7.1)
Peak 64.3 (12.4)
Resting wall motion abnormality 21 (13.6%)
Wall motion score index
Rest 1.04 (0.17)
Peak 1.22 (0.28)
Carotid ultrasound data
Mean CIMT (mm) 0.88 (0.19)
Mean CIMT percentile Spanish population
≤ 25th 18 (11.5%)
25th - 75th 40 (25.6%)
≥ 75th 98 (62.8%)
CP 95 (60.9%)
Calcified CP 47 (30.5%)
BP Blood pressure, CAD coronary artery disease, CIMT carotid intima-media
thickness, CP carotid plaque, DM diabetes mellitus, EE exercise
echocardiography, FPG fasting plasma glucose, GFR glomerular filtration rate,
SCORE European Systematic COronary Risk Evaluation
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studies [13–15], CI or comparison between AUC were
not reported. In contrast with previous results, Sachpe-
kidis [17] did not find any statistical association between
carotid and CAD (defined as positive dobutamine stress
test) in 130 patients, 43% of them with previous CAD.
However, the study population was small with only
38.5% yielding positive results, prior CAD could have
hampered its findings and there was no comparison with
angiography.
Atherosclerosis is a systemic disease and it is likely
that patients with carotid disease also have CAD. This
fact, as previously mentioned, was demonstrated in
post-mortem studies [8] and in Bots’ meta-analysis [19].
The highly variability of the association, with a correl-
ation range between − 0.04 - 0.51 in the aforementioned
meta-analysis, could be due to methodological differ-
ences in carotid ultrasound assessment and/or variability
in atherosclerosis development between the vascular ter-
ritories [19]. According to European and American
guidelines on the management of stable CAD [2, 3] PTP
of CAD must be established and then a non-invasive test
must be performed for diagnostic or prognostic pur-
poses depending on the degree of PTP. Both agree that a
history of cerebrovascular or peripheral artery disease
increases the likelihood of CAD [2, 3].
In our study most of the patients (96.2%) had inter-
mediate PTP and, most importantly, none of them
had previous vascular or CAD. Predictors positively
associated with significant CAD were positive EE
(OR = 10.51), PTP > 65% (OR = 3.71), CP (OR = 2.95)
and FPG levels (OR = 1.02). It is interesting to men-
tion that other important risk factors associated with
CAD such as hypertension, hypercholesterolemia,
cholesterol levels or smoking habit [1–3] were not
significantly associated with CAD in our study, this
fact can be explained due to insufficient statistical
power and due to treatment effect, for example 42
patients (47.2%) with significant CAD were taking sta-
tins at the time of EE performance while only 26
(38.8%) of subjects without CAD were taking them,
also 56 (62.9%) subjects with significant CAD where
on antihypertensive drugs compared to only 35
(52.2%) of patients without CAD. FPG not DM was
associated with CAD, the reason may be because the
development of macrovascular disease occurs with in-
sulin resistance, prior to DM diagnosis [27]; high or
very high-risk SCORE was not also associated with
CAD, probably because it is not designed to estimate
it, just the risk of a fatal atherosclerotic event [1]. Al-
though CP is the third in order in multivariable ana-
lysis after positive EE and PTP of CAD > 65%, it
increases by nearly 3 the likelihood of having signifi-
cant CAD so carotid ultrasound could be useful in
case of intermediate PTP, where diagnosis must be
Table 2 Clinical, demographic, exercise and carotid ultrasound
data in the subgroup of patients with and without CAD
CAD≥ 50%
(n = 89)
CAD < 50%
(n = 67)
p value
Age 67.6 (9.2) 64.1 (11.6) 0.045
Male sex 66 (74.2%) 36 (53.7%) 0.011
Body mass index 29.1 (4.2) 28.1 (3.7) 0.134
Hypertension 55 (61.8%) 38 (56.7%) 0.621
Hypercholesterolemia 56 (62.9%) 35 (52.2%) 0.193
DM 31 (34.8%) 10 (14.9%) 0.006
Smoking habit 46 (51.7%) 18 (32.8%) 0.023
Family history of early CAD 14 (15.7%) 8 (11.9%) 0.643
FPG levels 120.7 (38.7) 105.7 (22.4) 0.03
Total Cholesterol levels 192.0 (47.5) 185.5 (40.8) 0.379
Low-density lipoprotein levels 117.2 (40.7) 110.7 (36.1) 0.308
High-density lipoprotein levels 43.0 (11.3) 45.6 (12.1) 0.168
Triglyceride levels 160.6 (91.1) 157.2 (98.7) 0.824
GFR 75.6 (23.2) 81.1 (24.7) 0.105
SCORE < 0.001
Low 1 (1.1%) 9 (13.6%)
Moderate 24 (27.3%) 28 (42.4%)
High 28 (31.8%) 19 (28.8%)
Very high 35 (39.8%) 10 (15.2%)
PTP of CAD < 0.001
< 15% 0 (0%) 3 (4.5%)
15–65% 31 (34.8%) 42 (62.7%)
65–85% 55 (61.8%) 22 (32.8%)
> 85% 3 (3.4%) 0 (0%)
Positive EE 73 (82.0%) 20 (29.9%) < 0.001
Mean CIMT (mm) 0.88 (0.21) 0.89 (0.18) 0.926
CIMT > 0.9 mm 38 (42.7%) 31 (46.3%) 0.745
CIMT > 75th percentile 52 (58.4%) 46 (68.7%) 0.242
CP 66 (74.2%) 29 (43.3%) < 0.001
Calcified CP 32 (36.0%) 15 (22.4%) 0.079
PTP Pre-test probability. Rest of abbreviations as in Table 1
Table 3 Multivariate significant CAD analysis
Variable B p
value
OR 95% CI
Lower Higher
Constant −4.83 < 0.001 0.01
Smoking habit 0.84 0.057 2.31 0.98 5.46
FPG 0.02 0.031 1.02 1.00 1.04
PTP of CAD > 65% 1.31 0.003 3.71 1.57 8.79
Positive EE 2.35 < 0.001 10.51 4.38 25.20
CP 1.08 0.013 2.95 1.25 6.93
CI confidence interval, OR odds ratio. Rest of abbreviations as in Tables 1 and 2
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confirmed, or in equivocal EE. Moreover, and similar
to Ahmadvazir et al. [16], CP presence reclassified
around one third of patients to a high-risk category
despite a negative EE or a normal coronary angiog-
raphy. This is a very remarkable finding because these
subjects benefit from aggressive primary preventive
therapies [1] and, although ESC guidelines on cardio-
vascular disease prevention in clinical practice estab-
lish atherosclerotic plaque detection by carotid artery
scanning in cardiovascular risk assessment as a IIb
class level of evidence B recommendation [1], consid-
ering previously mentioned studies [7, 16] it might be
changed to a IIa recommendation. Finally, although
CP is associated with significant CAD its addition to
EE did not improve AUC (p = 0.525), predictive
values, efficiency and likelihood ratios due to CI
overlap. These facts can be explained by insufficient
statistical power, however it is important to mention
the markedly but statistically non-significant increase
in both NPV, especially in the moderate and high
PTP of CAD groups, and in the NLR. These findings,
although non-significant, are consistent to Kanwar et al.
[14] and Ahmadvazir et al. [16] studies where CI were not
reported. In this sense we considered our study only as
hypothesis generating and increasing sample could cor-
roborate it. Although there is a study addressing the utility
of carotid ultrasonography for selecting patients who do
not require coronary angiography before heart valve sur-
gery [28], in our study 25.8% of patients with significant
CAD did not have CP and 43.3% of patients without
significant CAD have CP in the carotid ultrasonog-
raphy. For that reason we consider non-invasive stress
test as the first line test in symptomatic patients with
intermediate PTP and carotid ultrasonography as an
additional tool for decision making. Unlike Kanwar
et al. [14] we did not specifically analysed CP morph-
ology, nevertheless we did not find significant associ-
ation between calcified CP and significant CAD, this
fact can be related to insufficient sample size.
Our study has some limitations. First of all, it is a
retrospective single institution study with a low recruit-
ment rate and therefore it is hampered by the use of dif-
ferent equipments and methods of image storage. One
alternative could be a multicentre prospective study.
Secondly, not all subjects with exercise and carotid tests
were submitted to angiography. As a consequence, there
are few patients with a negative EE (24.4%) in the sample
and prevalence of CAD could be higher in our group
than in the global population. Ideally, all subjects sched-
uled for EE and carotid ultrasonography should undergo
angiography. However, it seems unethical to submit to
an invasive, ionizing radiation exposing and expensive
procedure asymptomatic people after optimal lifestyle
and pharmacological management without bad-prognosis
EE. Other important limitation is that the coronary artery
stenosis percentage was assessed visually and not by using
more accurate tools such as intravascular ultrasound or
optical coherence tomography or by physiological
Fig. 1 Relationship between EE and CP and ROC curve representation. ROC: Receiver Operating Characteristic. Rest of abbreviation as in Tables 1,
2, 3 and 4
Table 4 Sensitivity, specificity, predictive values, AUC and likelihood ratios for CAD diagnosis
Conclusive EE (N = 131)
Sensitivity (95% CI) Specificity (95%CI) PPV (95% CI) NPV (95% CI) Efficiency (95% CI) AUC (95% CI) PLR NLR
EE 92.4% (84.4–96.5) 61.5% (48.0–73.5) 78.5% (69.1–85.6) 84.2% (69.6–92.6) 80.2% (72.5–86.1) 0.77 (0.68–0.86) 2.40 0.12
EE + CP 98.1% (90.1–99.7) 63.3% (45.5–78.1) 82.5% (71.4–90.0) 95.0% (76.4–99.1) 85.5% (76.4–91.5) 0.81 (0.70–0.92) 2.68 0.03
AUC area under the curve, NLR negative likelihood ratio, NPV negative predictive value, PLR positive likelihood ratio, PPV positive predictive value. Rest of abbreviations
as in Tables 1, 2 and 3
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assessment of CAD stenosis in the cardiac catheterization
laboratory (fractional flow reserve). This is a consequence
of a retrospective study design, when some techniques
were not available at the time of the angiography perform-
ance and it also reflects the usual clinical practice where
intermediate stenosis are treated in case of a positive
stress test and the methods mentioned before are used
according to interventional cardiologist criteria, if negative
or no stress test available. Comparison between carotid
ultrasound and intracoronary imaging techniques in
case of normal angiography could have helped to estab-
lish a better correlation between carotid and coronary
artery disease, however the aim of the study was to find
an association between carotid disease and significant
and possibly flow limiting epicardial coronary stenosis
causing chest pain. It is also important to keep in mind
that this is a real life cohort study and using intravascu-
lar ultrasound or optical coherence tomography in
people without intermediate CAD increases the cost
and the duration of the procedure. Finally, there are
13.6% of patients with resting wall motion abnormal-
ities, but we must consider that there are several condi-
tions other than ischemic heart disease, such as cardiac
sarcoidosis, myocarditis or cardiomyopathies that can
also cause them.
Conclusions
In conclusion, our study shows that carotid disease, in
particular the presence of CP, is associated with significant
CAD in patients submitted to EE. Its addition to EE does
not improve sensitivity, specificity, predictive values, likeli-
hood ratios, efficiency and AUC for significant CAD diag-
nosis; probably due to insufficient statistical power.
However, CP reclassified one third of patients to very
high-risk SCORE category despite a negative EE or CAD
absence and these subjects benefit from aggressive pri-
mary prevention interventions.
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